Published

Synthesis of a psilocin hapten and a protein-hapten conjugate

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Pharmacy and Pharmacology
Date: 2002-09-01
Source: Crossref
DOI: 10.1211/002235702320402116
PubMed: 12356281

Authors

Albers Christian Lehr Matthias Beike Justus Köhler Helga Brinkmann Bernd

Watch author

Derived topics and classifications

psilocin General Other

Citation graph

28 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

10.1021/bc00030a019 10.1016/0040-4039(95)01761-6 10.1016/s0021-9673(00)88741-5 10.1016/s0378-4347(00)00461-8 10.1007/s004140050291 10.1016/s0021-9673(00)91195-6 10.1007/s004140100204 10.1016/s0015-3796(86)80094-4 10.1520/jfs15014j 10.1016/s0031-6865(97)00014-9 10.1007/bf02166696 10.1007/bf02160424

Indexed papers citing this DOI

Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms2020-10-01 Development of a psilocin immunoassay for serum and blood samples2004-12-01 Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, Psilocin2004-01-01 Synthesis of a psilocin hapten and a protein-hapten conjugate2002-09-01

Related papers

Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategyEuropean Journal of Medicinal Chemistry Reports · 2025-12-01 Injury-Triggered Blueing Reactions of Psilocybe “Magic” MushroomsAngewandte Chemie · 2019-11-14 Development of a psilocin immunoassay for serum and blood samplesInternational Journal of Legal Medicine · 2004-12-01 Detection of Psilocybin and Psilocin in Norwegian Species ofPluteusandConocybePlanta Medica · 1984-08-01 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27 Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-StigmaSubstance Use & Misuse · 2026-03-28 A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond.RSC medicinal chemistry · 2024-03-20